Dr Audrey-Flore Ngomsik

Titanium dioxide nanoparticles found illegally in Sephora, Nocibé, René Furterer cosmetics. AVICENN investigation confirms EU Regulation 2022/1176 violations three years post-ban. French Health Ministry escalates to ANSES. Reformulation costs €200K minimum per product line. What's your company's regulatory exposure?

Over the past decade, while we were all watching these conferences with varying degrees of scepticism, something shifted. COP decisions stopped being theoretical and started showing up as line items on P&L statements. Some companies figured out how to profit from this. Others are still treating sustainability as a PR department problem. This is the story of what actually happened when climate diplomacy met quarterly reporting.

Climate change isn’t just melting ice caps—it’s raising women’s cancer risks. A new study links every 1°C rise in temperature to higher rates of breast, ovarian, uterine, and cervical cancers. As a CSR strategist, I argue this isn’t just a health issue—it’s a justice issue. Climate, gender, and health are colliding, and women are paying the price. It’s time to treat climate action as women’s health policy, and women’s health as climate strategy.